Carcinogenicity of the drinking water mutagen 3-chloro-4- (dichloromethyl)-5-hydroxy-2(5H)-furanone in the rat

Journal of the National Cancer Institute

Volumn 89, Issue 12, 1997, Pages 848-856

  Komulainen, Hannu ^a   Kosma, Veli Matti ^b   Vaittinen, Sirkka Liisa ^a   Vartiainen, Terttu ^a   Kaliste Korhonen, Eila ^b   Lötjönen, Simo ^b   Tuominen, Raimo K ^c   Tuomisto, Jouko ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORINE DERIVATIVE; DRINKING WATER;

ADENOCARCINOMA; ADENOMA; ADRENAL CORTEX ADENOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER RISK; CARCINOGENICITY; CHLORINATION; DOSE RESPONSE; LEUKEMIA; LUNG ADENOMA; LYMPHOMA; NONHUMAN; RAT; TOXICITY TESTING; WATER CONTAMINATION;

EID: 0030909235     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.12.848     Document Type: Article

References (33)

1. Chlorinated drinking-water. IARC Monogr Eval Carcinog Risks Hum 1991;52:45-141.
2. Kronberg L, Vartiainen T. Ames mutagenicity and concentration of the strong mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone and of its geometric isomer E-2-chloro-3-(dichloromethyl)-4-oxo-butenoic acid in chlorine-treated tap waters. Mutat Res 1988;206:177-82.
3. Meier JR, Knohl RB, Coleman WE, Ringhand HP, Munch JW, Kaylor WH, et al. Studies on the potent bacterial mutagen, 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone: aqueous stability, XAD recovery and analytical determination in drinking water and in chlorinated humic acid solutions [published erratum appears in Mutat Res 1988;204:723.] Mutat Res 1987;189:363-73.
4. Horth H, Fielding M, Gibon T, James HA, Ross H. Water Research Centre technical report PRD 2038-M, Medmeham, UK, 1989.
5. Andrews RC, Daignault SA, Laverdure C, Williams DT, Huck PM. Occurrence of the mutagenic compound 'MX' in drinking water and its removal by activated carbon. Environ Technol 1990;11:685-94.
6. Suzuki N, Nakanishi J. The determination of strong mutagen, 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone in drinking water in Japan. Chemosphere 1990;21:387-92.
7. Huixian Z, Jingi Z, Zhen Z. The determination of strong mutagen MX [3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone] in drinking water in China. Chemosphere 1995;30:2219-25.
8. Meier JR, Blazak WF, Knohl RB. Mutagenic and clastogenic properties of 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone: a potent bacterial mutagen in drinking water. Environ Mol Mutagen 1987;10:411-24.
9. Chang LW, Daniel FB, DeAngelo AB. DNA strand breaks induced in cultured human and rodent cells by chlorohydroxyfuranones - mutagens isolated from drinking water. Teratog Carcinog Mutagen 1991;11:103-14.
10. Jansson K, Hyttinen JM. Induction of gene mutation in mammalian cells by 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX), a chlorine disinfection by-product in drinking water. Mutat Res 1994;322:129-32.
11. Maki-Paakkanen J, Jansson K, Vartiainen T. Induction of mutation, sister-chromatid exchanges, and chromosome aberrations by 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone in Chinese hamster ovary cells. Mutat Res 1994;310:117-23.
12. Matsumura H, Watanabe M, Matsumoto K, Ohta T. 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX) induces gene mutations and inhibits metabolic cooperation in cultured Chinese hamster cells. J Toxicol Environ Health 1994;43:65-72.
13. +/- 3.7.2C mouse lymphoma cells. Mutat Res 1995;348: 105-10.
14. Furihata C, Yamasita M, Kinae N, Matsushima T. Genotoxicity and cell proliferative activity of 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone [MX] in rat glandular stomach. Water Sci Technol 1992;25:341-5.
15. Jansson K, Maki-Paakkanen J, Vaittinen SL, Vartiainen T, Komulainen H, Tuomisto J. Cytogenetic effects of 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX) in rat peripheral lymphocytes in vitro and in vivo. Mutat Res 1993;229:25-8.
16. Maki-Paakkanen J, Jansson K. Cytogenetic effects in the peripheral lymphocytes and kidney cells of rats exposed to 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX) orally on three consecutive days. Mutat Res 1995;343:151-6.
17. Morris RD, Audet AM, Angelillo IF, Chalmers TC, Mosteller F. Chlorination, chlorination by-products, and cancer: a meta-analysis [published erratum appears in Am J Public Health 1993;83:1257]. Am J Public Health 1992;82:955-63.
18. Morris RD. Drinking water and cancer. Environ Health Perspect 1995;103:225-31.
19. Koivusalo M, Jaakkola JJ, Vartiainen T, Hakulinen T, Karjalainen S, Pukkala E, et al. Drinking water mutagenicity and gastrointestinal and urinary tract cancers: an ecological study in Finland. Am J Public Health 1994;84: 1223-8.
20. Koivusalo M, Vartiainen T, Hakulinen T, Pukkala E, Jaakkola JJ. Drinking water mutagenicity and leukemia, lymphomas, and cancers of the liver, pancreas, and soft tissue. Arch Environ Health 1995;50:269-76.
21. Padmapriya AA, Just G, Lewis NG. Synthesis of 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)furanone, a potent mutagen. Canadian J Chem 1985;63:828-32.
22. The OECD principles of good laboratory practice. Environment Monogr No. 45. OECD series on principles of good laboratory practice and compliance monitoring, No. 1, 1992.
23. Vaittinen SL, Komulainen H, Kosma VM, Julkunen A, Maki-Paakkanen J, Jansson K, et al. Subchronic toxicity of 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX) in Wistar rats. Food Chem Toxicol 1995;33:1027-37.
24. McKenzie JM. The bioassay of thyrotropin in serum. Endocrinology 1958;63:372-82.
25. Peto R, Pike MC, Day NE, Gray RG, Lee PN, Parish S, et al. Guidelines for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments. IARC Monogr Eval Carcinog Risk Chem Hum Suppl 1980;311-426.
26. Daniel FB, Robinson M, Olson GR, Stober JA, Page NP. Toxicological studies on MX, a disinfection by product. J AWWA 1994;March:103-11.
27. Hill RN, Erdreich LS, Paynter OE, Roberts PA, Rosenthal SL, Wilkinson CF. Thyroid follicular cell carcinogenesis. Fundam Appl Toxicol 1989;12:629-97.
28. Thomas GA, Williams ED. Evidence for and possible mechanisms of non-genotoxic carcinogenesis in the rodent thyroid. Mutat Res 1991;248:357-70.
29. Goodman DG, Ward JM, Squire RA, Chu KC, Linhart MS. Neoplastic and nonneoplastic lesions in aging F344 rats. Toxicol Appl Pharmacol 1979;48:237-48.
30. Chandra M, Riley MG, Johnson DE. Spontaneous neoplasms in aged Sprague-Dawley rats. Arch Toxicol 1992;66:496-502.
31. McMartin DN, Sahota PS, Gunson DE, Hsu HH, Spaet RH. Neoplasms and related proliferative lesions in control Sprague-Dawley rats from carcinogenicity studies. Historical data and diagnostic considerations. Toxicol Pathol 1992;20:212-25.
32. Walsh KM, Poteracki J. Spontaneous neoplasms in control Wistar rats. Fundam Appl Toxicol 1994;22:65-72.
33. Komulainen H, Vaittinen SL, Vartiainen T, Lotjonen S, Paronen P, Tuomisto J. Pharmacokinetics in rat of 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX), a drinking water mutagen, after a single dose. Pharmacol Toxicol 1992;70:424-8.